News & Events: Lawson Lundell

On Thursday, April 12, 2018, Arbutus Biopharma Corporation (“Arbutus”), an industry-leading hepatitis B virus (HBV) therapeutic solutions company and Roivant Sciences Ltd. (“Roivant”) announced that they have entered into an agreement to launch Genevant Sciences (“Genevant”), a jointly-owned company focused on the discovery, development, and commercialization of a broad range of RNA-based therapeutics.

Paul Matthews, P.Eng. (AB) counsel in our Kelowna office led a working group session through Entrepreneurship at UBC discussing the topic of intellectual property for start-ups.

Craig Ferris, Q.C.,FCIArb has written a new Commercial Litigation and Dispute Resolution Blog post entitled, "Transactional Common Interest Privilege Recognized by the Federal Court of Appeal" discussing the Federal Court of Appeal’s recent decision on common interest privilege in a transactional context.

News & Publications

“British Columbia Creditor’s Remedies, An Annotated Guide”
CLE of BC, Annual, to date
"Law Society Practice Checklists – Examination in Aid of Execution"
Annual, to date

More >

Events & Speaking Engagements

Lawson Lundell Attends Looking Glass Foundation’s 14th Annual Gala
6.4.18
On Friday, April 6th, Will Roberts and various clients attended the Looking Glass Foundation’s 14th Annual Gala.
Intellectual Property for Start-ups
University of British Columbia, 15.3.18
Paul Matthews, P.Eng. (AB) counsel in our Kelowna office led a working group session through Entrepreneurship at UBC discussing the topic of intellectual property for start-ups.

More >

News & Events

News & Publications

Events & Speaking Engagements

Newsletter Sign Up >